HEMOSOL B0 sol 5.145 g 2x5000 ml

7680562020024 CH-56202 B05ZB 05.04.0.
HEMOSOL B0 sol 5.145 g 2x5000 ml
HEMOSOL B0 sol 5.145 g 2x5000 ml
HEMOSOL B0 sol 5.145 g 2x5000 ml
1 / 3
google

Details

GTIN
7680562020024
Pharmacode
-
Product number
5620201
CPT
-
Packaging group
2 x 5000
Unit
ml
Composition
Solutio reconstituta: natrium 140 mmol, chloridum 109.5 mmol, calcium 1.75 mmol, magnesium 0.5 mmol, (S)-lactas 3 mmol, hydrogenocarbonas, aqua ad iniectabile q.s. ad solutionem pro 1000 ml. B) Pufferlösung: natrii hydrogenocarbonas 3.09 g, natrii chloridum 6.45 g, carbonei dioxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1000 ml. A) Elektrolytlösung: calcii chloridum dihydricum 5.145 g, magnesii chloridum hexahydricum 2.033 g, acidum (S)-lacticum 5.4 g, aqua ad iniectabile q.s. ad solutionem pro 1000 ml.

Articles (1)

Hemosol B0, Hämofiltrationslösung
Hämofiltrationslösung
2 x 5000
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
09/10/2025
Professional SmPC
Français
09/10/2025
Professional SmPC
Italien
09/10/2025

Detailed composition

Substance Quantity Type Category
natrii hydrogenocarbonas
3.09 G Substance Wirkstoff (Principe actif)
natrium
140.0 MMOL Substance Wirkstoff (Principe actif)
calcii chloridum dihydricum
5.145 G Substance Wirkstoff (Principe actif)
magnesii chloridum hexahydricum
2.033 G Substance Wirkstoff (Principe actif)
chloridum
109.5 MMOL Substance Wirkstoff (Principe actif)
natrii chloridum
6.45 G Substance Wirkstoff (Principe actif)
calcium
1.75 MMOL Substance Wirkstoff (Principe actif)
acidum (S)-lacticum
5.4 G Substance Wirkstoff (Principe actif)
carbonei dioxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
magnesium
0.5 MMOL Substance Wirkstoff (Principe actif)
(S)-lactas
3.0 MMOL Substance Wirkstoff (Principe actif)
hydrogenocarbonas
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Vantive GmbH

8152 Opfikon

Authorization information

Swissmedic authorization number
56202
Drug name
Hemosol B0, Hämofiltrationslösung
Galenic form
HADF
ATC Code
B05ZB
Authorization status
Z
Dispensation category
B
First authorization
03/07/2003
Authorization expiration date
31/12/9999
IT number
05.04.0.
Domain
Human medicine
Field of application
Hämofiltration

Packaging details

Description (FR)
HEMOSOL B0 sol 5.145 g 2x5000 ml
Description (DE)
HEMOSOL B0 Lös 5.145 g 2x5000 ml
Market launch
01/03/2025
Narcotic (BTM)
No

Other packaging sizes

Buy us a coffee Explore the data